Market Access

Are you in touch with the latest payer thinking?

Payer and HTA submissions: how digital technology is transforming market access processes

Using Innovative Data Analytics for Market Access

Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?

Who Are the Real Change-Agents in Pharma Market Access? The Growing Role of Value Demonstration

Top 10 Clinical Trials Services

Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence

Network meta-analysis and its role in evidence-based decision-making

Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases

Market Access - Transforming BioTech Commercial Decisions?

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Beyond Accelerated Approvals: External Control Arms

Cell & Gene Therapies - Beginning with the End in Mind

Tracking and Measuring Market Access Performance

Medicare Part D: Price Negotiation Panel Discussion

Impact of the 2023 CMS Prior Authorization Rule

Stay Ahead of the Game: Learn How to Conduct an Evidence-Based GVD Faster and Smarter to Improve Market Access

Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data

Expediting drug product development and commercialization in global markets with global filing strategies

How to Unlock Market Access & Pricing Potential of Orphan Drugs

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval

New Insights into ATMP Valuation and Outcomes-Based Pricing Experience

Make Market Access Your Brand's Super Power - September 21st

US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations

Become an expert & hone your skills for Pharma, Biotech, Medical & Diagnostic Device launches

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

AMNOG impact on European countries?! Joint webinar with Medvance

Value-Based Agreements - Are We Going to See More or Less of Them?

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Predicting Payer Uptake with Precision

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap

INsights & OUTcomes with Taylor Hirschberg

Meeting the Resource Challenge - Why Biotechs Need a Different Kind of Partner

INsights & OUTcomes with Matt McLoughlin

INsights & OUTcomes with Rosa Willock

INsights & OUTcomes with Chris O'Neill

Podcast Q&A: EU HTA Joint Clinical Assessments

Podcast Q&A: Medicare and Medicaid Services Market Pricing

Podcast Q&A: Literature Reviews and Global Value Dossiers

Podcast Q&A: Discussing Health Technology Assessment Agencies

Podcast Q&A: Platforms and Models for Payer Insights and Evidence Generation